Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Pessoa (Lisbon, Portugal), C. Bárbara (Lisbon, Portugal), A. Costa (Lisbon, Portugal), P. Nogueira (Lisbon, Portugal). Factors associated with community-acquired pneumonia in-hospital mortality in Portugal. 1737

Member's Comments

No comment yet.

Related content which might interest you: Factors influencing in-hospital mortality in community-acquired pneumonia (CAP) Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 Predictive factors of in-hospital mortality of patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 352s Year: 2006 The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Factors associated with hospital mortality in community-acquired legionellosis in France Source: Eur Respir J 2012; 39: 963-970 Year: 2012 On improving assessment of in-hospital mortality and ICU admisison in community-acquired pneumonia patients by using the e-CURB Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Affecting factors of mortality in severe community-acquired pneumonia Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Factors affecting short and long-term mortality after community-acquired pneumonia Source: International Congress 2015 – CAP: prognostic factors in frail patients Year: 2015 3-day mortality in hospitalised community-acquired pneumonia: frequency and risk factors Source: Eur Respir J 2016; 47:1572-1574 Year: 2016 Analysis of mortality from community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 376s Year: 2006 Predictors of rehospitalization after admission for community-acquired pneumonia Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Analysis of the mortality caused by community-acquired pneumonia in the elderly Source: Eur Respir J 2005; 26: Suppl. 49, 544s Year: 2005 In-hospital mortality risk assessment in patients with community acquired pneumonia Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections Year: 2014 Incidence, risk factors and outcomes of cardiovascular events in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Intrahospital cardiovascular complications in severe community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues Year: 2016 The incidence and mortality rate of ventilator-associated pneumonia in elderly patients Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Risk factors of paediatric community-acquired pneumonia Source: Eur Respir J 2011; 37: 724-725 Year: 2011 Obesity is associated with improved survival in community-acquired pneumonia Source: Eur Respir J 2013; 42: 180-187 Year: 2013 Admission hypoglycaemia is associated with adverse outcome in community-acquired pneumonia Source: Eur Respir J 2009; 34: 932-939 Year: 2009